EGEN, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for EGEN, Inc..The latest application filed is for "combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases".

Company Profile

0.6.10

EGEN, Inc. - Huntsville AL
Egen, Inc. -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Combination of Immuno Gene Therapy and Chemotherapy for Treatment of Cancer and Hyperproliferative Diseases App 20140186375 - Fewell; Jason G. ; et al.	2014-07-03
Polyamine Derivatives App 20140050775 - Slobodkin; Gregory ; et al.	2014-02-20
Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases Grant 8,623,837 - Fewell , et al. January 7, 2	2014-01-07
Compositions and methods for the Delivery of Biologically Active RNAs App 20140005254 - Polach; Kevin ; et al.	2014-01-02
Compositions and methods for the delivery of biologically active RNAs Grant 8,569,065 - Polach , et al. October 29, 2	2013-10-29
Polyamine Derivatives App 20130251809 - Slobodkin; Gregory ; et al.	2013-09-26
Polyamine derivatives Grant 8,460,696 - Slobodkin , et al. June 11, 2	2013-06-11
Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof Grant 8,445,017 - Slobodkin , et al. May 21, 2	2013-05-21
Nucleic Acid-Lipopolymer Compositions App 20130065942 - Matar; Majed ; et al.	2013-03-14
Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof Grant 8,057,821 - Slobodkin , et al. November 15, 2	2011-11-15
Combination of Immuno Gene Therapy and Chemotherapy for Treatment of Cancer and Hyperproliferative Diseases App 20110218231 - Fewell; Jason G. ; et al.	2011-09-08
Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases Grant 7,964,571 - Fewell , et al. June 21, 2	2011-06-21
Polyamine Derivatives App 20100260817 - Slobodkin; Gregory ; et al.	2010-10-14
Compositions And Methods For The Delivery Of Biologically Active RNAs App 20100233141 - Polach; Kevin ; et al.	2010-09-16

Company Registrations

NCAGE Code	515HF	EGEN INC.
CAGE Code	515HF	EGEN INC.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.